Side-by-side comparison of AI visibility scores, market position, and capabilities
New York world's largest asset manager (NYSE: BLK) at $12.5T AUM; record $641B 2024 net inflows, $28B acquisition program (GIP $12.5B + HPS $12B + Preqin $3.2B) building private markets platform competing with Vanguard and Fidelity.
BlackRock, Inc. is a New York City, New York-based global investment management company — publicly traded on the New York Stock Exchange (NYSE: BLK) as an S&P 500 Financials component — managing $12.5 trillion in assets under management (AUM) as the world's largest asset manager through over 19,000 employees serving institutional and individual investors in 100 countries from 70 offices in 30 countries. Founded in 1988 by CEO Larry Fink and seven partners as a fixed income risk management firm, BlackRock grew through landmark acquisitions including Merrill Lynch Investment Managers ($9.8B, 2006), Barclays Global Investors ($13.5B, 2009, which added iShares — the world's largest ETF platform with 400+ funds), and in 2024-2025, a $28 billion acquisition program including Global Infrastructure Partners ($12.5B), HPS Investment Partners ($12B, private credit), and Preqin ($3.2B, private markets data analytics). In full year 2024, BlackRock reported record net inflows of $641 billion, 14% revenue growth (reaching $5.19 billion), diluted EPS of $42.01 ($43.61 adjusted), and a 29% total shareholder return. AUM reached $11.6 trillion at end of 2024 and grew to $12.5 trillion by 2025 incorporating the infrastructure and private credit acquisitions. BlackRock's Aladdin technology platform (managing $21.6+ trillion across internal and external clients as of 2020) provides portfolio construction, risk analytics, and operations infrastructure to asset managers, pension funds, insurance companies, and sovereign wealth funds globally.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.